Literature DB >> 28891095

Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.

Bao-Jian Guo1, Zhao-Xiang Bian2, Hong-Cong Qiu3, Yi-Tao Wang1, Ying Wang1.   

Abstract

Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders that includes Crohn's disease (CD) and ulcerative colitis (UC). Homeostasis of various regulatory factors involved with intestinal immunity is disrupted in IBD, including the intestinal epithelial barrier, macrophages, and cellular mediators such as cytokines and chemokines. No successful treatment is currently available for the management of IBD. Natural products and herbal medicines have exhibited efficacy for UC and CD in experimental models and clinical trials with the following activities: (1) maintenance of integrity of the intestinal epithelial barrier, (2) regulation of macrophage activation, (3) modulation of innate and adaptive immune response, and (4) inhibition of TNF-α activity. Here, we discuss the major factors involved in the pathogenesis of IBD and the current development of natural products and herbs for the treatment of IBD.
© 2017 New York Academy of Sciences.

Entities:  

Keywords:  Crohn's disease; herbal medicine; inflammatory bowel disease; natural products; ulcerative colitis

Mesh:

Substances:

Year:  2017        PMID: 28891095     DOI: 10.1111/nyas.13414

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  26 in total

1.  Arjunarishta alleviates experimental colitis via suppressing proinflammatory cytokine expression, modulating gut microbiota and enhancing antioxidant effect.

Authors:  Damita Cota; Sanjay Mishra; Sushant Shengule
Journal:  Mol Biol Rep       Date:  2020-09-03       Impact factor: 2.316

2.  The effects of dihydroartemisinin on inflammatory bowel disease-related bone loss in a rat model.

Authors:  Xingtao Ge; Zhijian Chen; Zhenjie Xu; Fang Lv; Kewei Zhang; Yu Yang
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

3.  Saffron Pre-Treatment Promotes Reduction in Tissue Inflammatory Profiles and Alters Microbiome Composition in Experimental Colitis Mice.

Authors:  Suhrid Banskota; Hassan Brim; Yun Han Kwon; Gulshan Singh; Sidhartha R Sinha; Huaqing Wang; Waliul I Khan; Hassan Ashktorab
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

4.  The protective effects of magnolol on acute trinitrobenzene sulfonic acid‑induced colitis in rats.

Authors:  Yong Zhang; Li-Tang Fu; Fang Tang
Journal:  Mol Med Rep       Date:  2017-12-20       Impact factor: 2.952

5.  Efficacy and safety of Tripterygium wilfordii Hook F preparations for the treatment of Crohn disease: A systemic review and meta-analysis protocol.

Authors:  Jianying Zhang; Gang Han; Zhenwei Yu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

6.  Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients.

Authors:  Carla Marinelli; Edoardo Savarino; Marco Inferrera; Greta Lorenzon; Alessandra Rigo; Matteo Ghisa; Sonia Facchin; Renata D'Incà; Fabiana Zingone
Journal:  Gastroenterol Res Pract       Date:  2019-08-21       Impact factor: 2.260

7.  Korean Traditional Medicine (Jakyakgamcho-tang) Ameliorates Colitis by Regulating Gut Microbiota.

Authors:  Seung-Ho Seo; Tatsuya Unno; Seong-Eun Park; Eun-Ju Kim; Yu-Mi Lee; Chang-Su Na; Hong-Seok Son
Journal:  Metabolites       Date:  2019-10-14

Review 8.  Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease.

Authors:  Tripti Khare; Sushesh Srivatsa Palakurthi; Brijesh M Shah; Srinath Palakurthi; Sharad Khare
Journal:  Int J Mol Sci       Date:  2020-05-31       Impact factor: 5.923

9.  Periplaneta americana Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats by Keap1/Nrf-2 Activation, Intestinal Barrier Function, and Gut Microbiota Regulation.

Authors:  Xuewei Ma; Yichen Hu; Xin Li; Xiaoting Zheng; Yitao Wang; Jinming Zhang; Chaomei Fu; Funeng Geng
Journal:  Front Pharmacol       Date:  2018-08-22       Impact factor: 5.810

10.  Exploring the Mechanism of Berberine Intervention in Ulcerative Colitis from the Perspective of Inflammation and Immunity Based on Systemic Pharmacology.

Authors:  Yan Jiang; Li Zhao; Qing Chen; Lihong Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.